Neoadjuvant L19IL2/L19TNF- Pivotal Study

Clinical trial NCT02938299 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02938299
Sponsor: Philogen S.p.A.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2016-07-01
Primary completion: 2024-10-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.